Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
06/30/2021
Hasılat
902
860
800
717
322
611
Hasılat Artışı (YoY)
8%
8%
12%
123%
-47%
28%
Satınalma Maliyeti
476
461
444
407
197
359
Brüt Kâr
425
399
356
310
124
251
Satış, Genel ve İdari
332
338
338
357
171
211
Araştırma ve Geliştirme
36
35
31
30
17
29
İşletme Giderleri
369
373
370
387
188
240
Diğer Finansman Gelirleri (Giderleri)
0
-5
-24
0
-1
1
Kâr Öncesi Gelir
25
-33
-105
-306
-141
-164
Kira Vergisi Gideri
-2
2
-6
-18
-12
-5
Net Kâr
26
-36
-96
-276
-127
-158
Net Income Growth
Kâr Artışı
-139%
-63%
-65%
117%
-20%
33%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
255.66
204.99
196.36
181.1
199.52
199.5
Hisse Değişimi (Yıllık Üst Üste)
24%
4%
8%
-9%
0%
0%
EPS (Diluted)
0.11
-0.17
-0.49
-1.53
-0.64
-0.79
EPS Artışı
-136%
-64%
-68%
139%
-19%
32%
Öz sermaye akışı
92
50
58
5
-16
30
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
47.11%
46.39%
44.5%
43.23%
38.5%
41.08%
Faaliyet Kâr Marjı
6.2%
3.02%
-1.62%
-10.73%
-19.87%
1.8%
Kâr Marjı
2.88%
-4.18%
-12%
-38.49%
-39.44%
-25.85%
Özsermaye Karlılık Oranı
10.19%
5.81%
7.24%
0.69%
-4.96%
4.9%
EBITDA
193
176
149
97
-1
94
EBITDA Marjinali
21.39%
20.46%
18.62%
13.52%
-0.31%
15.38%
D&A EBITDA için
137
150
162
174
63
83
Faaliyet Kârı
56
26
-13
-77
-64
11
Faaliyet Kâr Marjı
6.2%
3.02%
-1.62%
-10.73%
-19.87%
1.8%
Verilen Vergi Oranı
-8%
-6.06%
5.71%
5.88%
8.51%
3.04%
360Rapor
Önemli İstatistikler
Önceki Kapanış
$21.48
Açılış fiyatı
$21.4
Günün Aralığı
$21.01 - $22.55
52 haftalık aralık
$12 - $30.27
İşlem hacmi
4.5M
Ort.Hacim
3.3M
EPS (TTM)
0.12
Dividend yield
--
Piyasa Değeri
$5.7B
MIR nedir?
Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. The company is headquartered in Atlanta, Georgia and currently employs 2,860 full-time employees. The company went IPO on 2020-06-29. The firm's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).